Salix Pharmaceuticals has promoted William P. Forbes, PharmD, to chief development officer and president of medical, research and development.
Prior to his promotion, Dr. Forbes was CDO and executive vice president of medical, research and development. He has been with Salix for 10 years.
“Bill has been instrumental in developing and managing all aspects of our research and development efforts and advancing numerous products through our pipeline to regulatory approval,” said chairman of the board and acting CEO Thomas W. D’Alonzo.